• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Establishment of novel therapeutic modalities for gastric cancer by using flavonoid

Research Project

Project/Area Number 16591351
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionSaitama Medical School (2005)
Keio University (2004)

Principal Investigator

OTANI Yoshihide  Saitama Medical School, Department of Surgery, Professor, 医学部, 教授 (20168983)

Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 2004: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordsgastric cancer / flavonoid / MMP / peritoneal dissemination / metastasis / synergistic effect / apoptosis / G1 arrest
Research Abstract

Aims : Matrix metalloproteinases (MMPs) can degrade variety of extracellular matrices (ECM) including collagen, laminin, proteoglycan and so on. The destruction of ECM components during cancer invasion and metastasis is well recognized. Recently, citrus flavonoids including nobiletin are known to suppress MMPs production and to exert anticancer activity in vitro. We have already reported the suppression of peritoneal nodule formation of gastric cancer cells in peritoneal dissemination model of SCID mouse (Jpn J Cancer Res, 92 : 1322-1328, 2001). Therefore, we plan to figure out the anti-tumor effects of nobiletin on gastric cancer cells from several aspects. Materials and methods : Human gastric cancer cell lines, TMK-1, MKN-45, MKN-74 and KATO-III were used for this study. The direct cytotoxicity of nobiletin was examined by MTT assay, the induction of apoptosis was investigated by TUNEL method and the effect on cell cycle was measured by DNA histogram using flow cytometry. Results : Nobiletin significantly showed the direct cytotoxicity on the four cell lines examined. Apoptosis was observed and the block of cell cycle was evident at G1 phase by nobiletin. Conclusion : The control of ECM destruction, direct cytotoxicity, the induction of apoptosis and G1 arrest on gastric cancer cells caused by nobiletin, represent a potential strategy for the treatment of gastric cancer.

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • Research Products

    (17 results)

All 2005 2004

All Journal Article (17 results)

  • [Journal Article] 胃癌に対する化学療法・放射線療法の現状2005

    • Author(s)
      才川義朗, 吉田 昌, 大谷吉秀, 他
    • Journal Title

      臨床外科 60・6

      Pages: 735-41

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] 集学的治療により長期生存を得た腹膜播種を伴う4型胃癌の1例2005

    • Author(s)
      才川義朗, 大谷吉秀, 他
    • Journal Title

      胃と腸 40・7

      Pages: 1027-30

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Is chemoradiation effective or harmful for stage VI gastric cancer patients?2005

    • Author(s)
      Saikawa Y, Kubota T, Otani Y, et al.
    • Journal Title

      Oncol Rep 13・5

      Pages: 865-70

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Tyrosine kinase inhibitor SU6668 inhibits pertoneal dissemination of gastric cancer via suppression of tumor angiogenesis.2005

    • Author(s)
      Tokuyama J, Kubota T, Saikawa Y, Otani Y, et al.
    • Journal Title

      Anticancer Res 25

      Pages: 17-22

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes.2005

    • Author(s)
      Aoki M, Saikawa Y, Otani Y, et al.
    • Journal Title

      Anticancer Res 25

      Pages: 3791-8

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Is chemoradiation effective of harmful for stage VI gastric cancer patients?2005

    • Author(s)
      Saikawa Y, Kubota T, Otani Y, et al.
    • Journal Title

      Oncol Rep 13 (5)

      Pages: 865-870

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.2005

    • Author(s)
      Tokuyama J, Kubota T, Saikawa Y, Otani Y, et al.
    • Journal Title

      Anticancer Res 25

      Pages: 17-22

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] センチネルリンパ節生検による新しい早期胃癌治療への試み2005

    • Author(s)
      大谷吉秀 他
    • Journal Title

      胃と腸 40・1

      Pages: 112-118

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 胃癌に対する化学療法・放射線療法の現状2005

    • Author(s)
      才川義朗, 吉田 昌, 大谷吉秀 他
    • Journal Title

      臨床外科 60・6

      Pages: 735-741

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 集学的治療により長期生存を得た腹膜播種を伴う4型胃癌の1例2005

    • Author(s)
      才川義朗, 大谷吉秀 他
    • Journal Title

      胃と腸 40・7

      Pages: 1027-1030

    • Related Report
      2005 Annual Research Report
  • [Journal Article] 消化器癌における血管新生の意義-臨床試験の現状-2004

    • Author(s)
      大谷吉秀, 他
    • Journal Title

      G. I. Research 12・5

      Pages: 393-400

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Clinical and Pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low dose cisplatin.2004

    • Author(s)
      Akatsu Y, Saikawa Y, Kubota T, Otani Y, et al.
    • Journal Title

      Gastric Cancer 7・1

      Pages: 128-133

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Anti-tumor effects of nobiletin, a citrus flavonoid, on gastric cancer include-antiproliferative effects, induction of apoptosis and cell cycle deregulation - implications for combination therapy with anticancer drugs.2004

    • Author(s)
      Yoshimizu N, Otani Y, et al.
    • Journal Title

      Aliment Pharmacol Therapeut 20(supple 1)

      Pages: 95-101

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.2004

    • Author(s)
      Maeda S, Sugiura T, Saikawa Y, Kubota T, Otani Y, et al.
    • Journal Title

      Cancer Sci 95・8

      Pages: 679-684

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.2004

    • Author(s)
      Yokoyama T, Nakamura H, Otani Y, et al.
    • Journal Title

      Clinical and Experimental Metastasis 21・3

      Pages: 223-233

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.2004

    • Author(s)
      Toriumi F, Kubota T, Saikawa Y, Yoshida M, Otani Y, et al.
    • Journal Title

      Anticancer Res 24

      Pages: 2455-2464

    • Related Report
      2004 Annual Research Report
  • [Journal Article] 消化器癌における血管新生の意義-臨床試験の現状2004

    • Author(s)
      大谷吉秀, 久保田哲朗, 才川義朗, 他
    • Journal Title

      G.I.Research 12・5

      Pages: 393-400

    • Related Report
      2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi